To trigger an effective antitumor response, it not only requires dendritic cells (DCs) to take up the cancer cell surface antigen and cross-presented to activate CD8 T cells but also, the tumor with the antigen must be recognized accurately and thus killing by the T cells. This evidence concerns the gene CD8A and neoplasm.